Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07223268 · ClinicalTrials.gov registry record · NA

Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation

A NA study of Diabetic Foot Ulcer, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
270
Enrollment target
1
Study location

NCT07223268 is a NA study of Diabetic Foot Ulcer that is actively recruiting participants, run by Emory University. The registered enrollment target is 270 participants, roughly in line with the 251-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07223268, a NA study of Diabetic Foot Ulcer, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
270 participants
Enrollment target
1
Study location

Study Summary

The purpose of this interventional study is to assess the effectiveness of CARE-D-Foot, a patient navigator intervention, as compared to usual care, on 20-week diabetic foot ulcer healing. The study will further: * Evaluate fidelity to and acceptability of the CARE-D-Foot-Nav program using mixed methods * Perform a CARE-D-Foot-Nav cost-effectiveness analysis (CEA)

Conditions Studied

Interventions

  • OTHER Standard of care
  • OTHER CARE-D-Foot-Nav

Study Locations (1)

Georgia

  • Grady Memorial Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2025-10-07
Est. Completion 2030-08
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT07223268

The ClinicalTrials.gov registry entry for NCT07223268 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 251-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.

NCT07223268 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT07223268 about?

NCT07223268 is a clinical study titled "Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation". The purpose of this interventional study is to assess the effectiveness of CARE-D-Foot, a patient navigator intervention, as compared to usual care, on 20-week diabetic foot ulcer healing. The study will further: * Evaluate fidelity to and acceptability of the CARE-D-Foot-Nav program using mixed m...

What is the current status of trial NCT07223268?

This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2025-10-07. Estimated completion is 2030-08.

What conditions does trial NCT07223268 study?

This clinical trial studies the following conditions: Diabetic Foot Ulcer.

What interventions are being tested in trial NCT07223268?

The interventions under investigation include: Standard of care (OTHER), CARE-D-Foot-Nav (OTHER).

Who is sponsoring clinical trial NCT07223268?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07223268 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Foot Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.